Key facts
- This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2022, 17:26.
Jon Snodgres - 01 Aug 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RGEN
- Reported as of
- 01 Aug 2022
- Net transaction value
- -$440,000
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2022, 17:26:40 UTC
- Prior SEC filing
- 17 May 2022
- Next SEC filing
- 17 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberly Brown (Attorney in Fact)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 02 Aug 2022.
Change
- Previous filing in this sequence was filed on 17 May 2022.
- Current net transaction value: -$440,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGEN
transaction
Common Stock
Sale
- Transaction value
- -$440,000
- Shares
- -2,000
- Change %
- -5.1%
- Price
- $220.00
- Shares after
- 37,187
- Date
- 01 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022.